European Union countries annoyed over delayed Pfizer coronavirus vaccine

Some EU nations are upset over the delayed delivery of the COVID-19 vaccine by Pfizer. The six European countries have complained that they are battling against time to give their citizens protection against the virus.

Six EU countries receive fewer vaccines from Pfizer

Many EU nations seem to be getting a lower dose of the Pfizer vaccine than promised due to fewer deliveries by the US pharmaceutical firm.

These countries are annoyed and termed this act as “ unacceptable and frustrating” and issued a warning that this action could affect the credibility of the whole vaccination plan.

The EU nations affected include Sweden, Denmark, Latvia, Estonia, Finland, and Lithuania. They have asked the European Union to put more pressure on the Pfizer Biotech firm to speed up the delivery as expected.

Pfizer has issued a statement saying the slow deliveries are unfortunate and temporary. They further said that they are doing everything possible to hasten the process.

Pfizer has insisted on delay due to production enhancements

In a statement issued on Saturday, the medical firm stated that vaccine shipments are affected due to changes in some of its manufacturing operations intended to alleviate production.

“ This unfortunate issue will affect deliveries in January and February, but we are hopeful that from February ending to March, it will be better” Pfizer stated.

Additionally, the European Union has also given the go-ahead to other vaccines like the Moderna, to provide viable alternatives to EU nations who can’t have access to Pfizer vaccines quickly. However, the ministry of health in Germany has said it is surprising and sad that other European nations cannot get the vaccines earlier like promised.

They promise to look into the issue swiftly. The president of the EU, Ursula Vin Der Leyen said she got assurance that all promised deliveries will be actualized before March-end. This promise may not be enough to calm down the nerves of EU nations affected, as they face a surging second wave of the COVID-19 virus.